Step Pharma, SAS
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial (NCT06786234) | Step Pharma, SAS | 2025-06-18 |
| Study of STP938 (Dencatistat) in Advanced Solid Tumours (NCT06297525) | Step Pharma, SAS | 2024-08-02 |
| A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas (NCT05463263) | Step Pharma, SAS | 2022-08-03 |
Track Step Pharma, SAS automatically
Every clearance here is in the API, with alerts when new ones post.